Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P1.01 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Epidemiology/Tobacco Control and Cessation/Prevention
- Presentations: 59
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.01-016 - An International Epidemiological Analysis of Young Patients Diagnosed with NSCLC (AduJov - CLICaP)
14:30 - 14:30 | Author(s): L. Corrales-Rodriguez
- Abstract
Loading...
-
+
P1.02 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Biology/Pathology
- Presentations: 87
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.02-050 - Acquired Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs) in EGFR-Mutant Lung Adenocarcinoma among Hispanics (Rbiop-CLICaP)
14:30 - 14:30 | Author(s): A.F. Cardona
- Abstract
Loading... -
+
P1.02-058 - EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients (MutP-CLICAP)
14:30 - 14:30 | Author(s): A.F. Cardona
- Abstract
Loading...
-
+
OA10 - EGFR Mutations
- Type: Oral Session
- Track: Biology/Pathology
- Presentations: 8
- Moderators:J. Spicer
- Coordinates: 12/06/2016, 11:00 - 12:30, Strauss 1
-
+
OA10.03 - YAP-NOTCH and STAT3 Signaling Rebound as a Compensatory Response to Gefitinib or Osimertinib Treatment in EGFR Mutant Lung Cancer
11:20 - 11:30 | Author(s): R. Rosell
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.03a - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 72
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03a-007 - Pem/CBP/Bev Followed by Pem/Bev in Hispanic Patients with NSCLC: Outcomes According to Combined Score of TS, ERCC1 and VEGF Expression
14:30 - 14:30 | Author(s): A.F. Cardona
- Abstract
Loading...
-
+
P2.03b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 98
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03b-025 - Mutation Profile and Histology Subtype According to IASLC/ERS/ATC as Risk Factors for Brain Metastases in Lung Adenocarcinoma
14:30 - 14:30 | Author(s): L. Ramirez-Tirado
- Abstract
Loading... -
+
P2.03b-083 - Soluble Angiogenic Factors as Predictive Biomarkers of Response to Docetaxel plus Nintedanib as Second Line Therapy in NSCLC
14:30 - 14:30 | Author(s): D. Lee-Cervantes
- Abstract
Loading...
-
+
P3.01 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Biology/Pathology
- Presentations: 64
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.01-014 - Differential Gene Expression of Lung Adenocarcinoma Histology Subtypes According to the IASLC/ATS/ERS Classification
14:30 - 14:30 | Author(s): O. Arrieta
- Abstract
Loading...
-
+
P3.02b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 126
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02b-047 - Co-Activation of STAT3 and YAP1 Signaling Pathways Limits EGFR Inhibitor Response in Lung Cancer
14:30 - 14:30 | Author(s): N. Karachaliou
- Abstract
Loading... -
+
P3.02b-125 - Failure to Tyrosine Kinase Inhibitors and Patterns of Progression in Patients with Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): F. Barron
- Abstract
Loading...
-
+
P3.03 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Presentations: 63
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.03-035 - Prognostic Role of hENT1 and RRM1 in Patients with Advanced Pleural Mesothelioma Treated with Second Line Gemcitabine Based Regimens
14:30 - 14:30 | Author(s): A.F. Cardona
- Abstract
Loading... -
+
P3.03-045 - Treatment of Malignant Pleural Mesothelioma beyond First-Line among Hispanics (MeSO-CLICaP)
14:30 - 14:30 | Author(s): L. Corrales
- Abstract
Loading... -
+
P3.03-048 - Profiling Response to Chemotherapy in Malignant Pleural Mesothelioma among Hispanics (MeSO-CLICaP)
14:30 - 14:30 | Author(s): A.F. Cardona
- Abstract
Loading... -
+
P3.03-060 - Characteristics and Long Term Outcomes of Advanced Pleural Mesothelioma in Latin America (MeSO-CLICaP)
14:30 - 14:30 | Author(s): O. Arrieta
- Abstract
Loading...
